Decreased TCF1 and BCL11B expression predicts poor prognosis for patients with chronic lymphocytic leukemia.

Front Immunol · 2022 · PMC9539190 · PMID 36211334

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

not yet significantno p-value reported

Although the data were not yet significant enough, this, to some extent, explains why decreased TCF1 and BCL11B expression leads to poor prognosis for patients with CLL.

also in 313 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.